Orthobiologics Market to Reach US$ 8261.6 Mn by 2026, Growing Patient Awareness Drives Market | Fortune Business Insights

The global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The Global Orthobiologics Market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Orthobiologics Market is likely to gain traction on account of rising geriatric population, which in turn is indicative of the increasing prevalence of chronic arthritis. Fortune Business Insights published a report, titled “Orthobiologics Market Size, Share and Global Trend by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics) and Geography Forecast till 2025” which offers valuable insights into the drivers positively impacting the global market.

As per this report, the global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The global orthobiologics market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/orthobiologics-marke-100173

Demand for Spinal Fusion Method Expected to Increase

A lead analyst at Fortune Business Insights said, “Spinal fusion covered the highest share in the global orthobiologics market in 2018 owing to the rising prevalence of traumatic injuries and accidents.” “The advantages offered by orthobiologics regarding the treatment of spine-related injuries may fuel the demand for spinal fusion method,” he continued. Another application called soft tissue repair is anticipated to witness the highest growth on account of escalating demand for orthobiologics in cartilage repair. Rising incidence of sports injuries is also responsible for driving the soft tissue repair segment.

Favorable Reimbursement Policies Supports Growth in North America

From a geographical standpoint, North America is expected to lead the global orthobiologics market between 2028 and 2026. In 2018, the market for orthobiologics in North America has valued at US$ 2326.2 Mn. Favourable reimbursement policies in the U.S. and rising adoption of advanced orthobiologics therapies are key factors contributing to the market’s growth in the region. The rising demand for a better quality healthcare in North America is also expected to create growth opportunities for the orthobiologics market in the region. Trailing North America, Europe is the second most prominent region, covering a significant share in the global market for orthobiologics. Growth of the orthobiologics market in Europe is attributable to recent FDA approvals for orthobiologics products. The rising demand for viscosupplements and increasing number of orthopaedic clinics are factors driving the orthobiologics market in Asia Pacific.

BioFiber by Tornier and Similar Product Developments to Boost Growth

The global orthobiologics market is driven by emerging technologies in orthobiologics treatment. For instance, a technology called 3D printed implant offers better stability and significantly reduces surgery time. A global leader in orthopaedics called Tornier has launched BioFiber Surgical Mesh. This technology helps to repair ligament injuries and other muscle injuries. Growing geriatric population is another factor fuelling demand for orthobiologics products such as orthobiologics injections. The rising clearances for several orthobiologics products is driving the orthobiologics market during the forecast period. Other factors likely to boost the orthobiologics market include increasing demand for advanced treatment and high growth potential especially in emerging countries.

Stringent Regulations and High Cost May Restrict the Market to Grow

Although the orthobiologics market is growing considerably, there are some factors that may hamper the growth. These include high costs associated with orthobiologics treatment. People in low-income regions cannot afford such treatments and this may pose a serious threat to the growth of the orthobiologics market. Another factor hampering the market is strict approval process for orthobiologics treatment and products.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/orthobiologics-marke-100173

NuVasive’s Launch of Propel DBM in 2018, to Boost its Market Position

Some of the leading players presently operating in the global orthobiologics market are Medtronic, Stryker, Sanofi, Zimmer Biomet, Bioventus, Sea Spine, Musculoskeletal Transplant Foundation, Wright Medical Group N.V., and RTI Surgical Holdings, Inc. Companies are focussing on launching new and technologically advanced orthobiologic products to increase their share in the orthobiologics market. For instance, NuVasive announced the launch of a new product called Propel DBM in 2018. This product helps to encourage bone growth among patients suffering from bone disorders.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/orthobiologics-market-to-reach-us-82616-mn-by-2026-growing-patient-awareness-drives-market-fortune-business-insights/513471

Source: MarketersMedia

Release ID: 513471

More News From Spotify News

Denmark's Lucas Bjerregaard has 2019 PGA's only hole-in-one

May 20, 2019

FARMINGDALE, N.Y. — Lucas Bjerregaard (BEER'-gard) and playing partner Lucas Glover did the old 1-2 on No. 17 at Bethpage Black in the final round of the PGA Championship. Bjerregaard, a 27-year-old Dane, made the first hole-in-one in the tournament on Sunday, one-bouncing a 6-iron into the cup on the par-3 206-yard hole. Bjerregaard high-fived his caddie, waved to the crowd and then walked to the green. He pulled his ball out of the hole and tossed it into the crowd. He had played the hole at 2 over in the first three rounds. It was the 42nd hole-in-one in...

Guerrero Jr. homers again, Blue Jays beat White Sox 5-2

May 20, 2019

CHICAGO — Following a slow start, Vladimir Guerrero Jr. is showing why he's one of the top prospects in the majors. Guerrero hit another home run, Danny Jansen and Billy McKinney also connected and the Toronto Blue Jays beat the Chicago White Sox 5-2 on Sunday. Guerrero has hit all four of his homers in the past six games and is 7 for 21 with nine RBIs during that span. The 20-year-old didn't homer in his first 13 games after making his debut in late April. "Like I always say, I don't try to hit homers," Guerrero said through a...

Chavis homers, Red Sox snap Astros' 10-game win streak

May 20, 2019

BOSTON — Michael Chavis pointed to a young boy in the press box, letting him know how impressed he was that a 5-year-old announced his name so well. Boston's rookie sparkplug then stepped to the plate and gave the kid something extra to be excited about. Chavis homered on the next pitch after acknowledging the boy, Xander Bogaerts hit a tiebreaking double in the seventh inning and the Red Sox averted a series sweep against Houston with a 4-3 victory Sunday that snapped the Astros' 10-game winning streak. "I heard a kid's voice and I looked up and I was...

Gardner, Yankees take advantage of walks, rout Rays 13-5

May 20, 2019

NEW YORK — In a season they never quite envisioned, the New York Yankees broke loose for their biggest inning of the year in a way they didn't imagine. Brett Gardner homered early, then got two hits during a seven-run burst in the sixth inning fueled by five walks that sent the Yankees past the Tampa Bay Rays 13-5 on Sunday. The Yankees took their second straight weekend series with Tampa Bay and moved a half-game in front atop the AL East. The Rays had been alone in first place for 47 straight days before New York scored three times...

The Latest: Pagenaud fights for job by winning Indy 500 pole

May 20, 2019

INDIANAPOLIS — The Latest on Indianapolis 500 qualifying (all times local): 5:45 p.m. Simon Pagenaud has won the pole for the Indianapolis 500, strengthening his case for keeping his job at Team Penske. Pagenaud averaged 229.992 mph in four laps of Sunday qualifying to lock down the top spot for the May 26 race. Pagenaud has been in the rumor mill for some time because of a long losing streak that he finally snapped last week on the road course around Indianapolis Motor Speedway. Now he's on the pole for the race boss Roger Penske rates most important. Penske has...

About Us

Sportify News offers you high quality sports journalism. Take a deep look in the world of sports as we bring you the latest news on acquisitions, sponsorships, lineups and more!

Contact us: sales[at]sportifynews.com

Subscribe Now!